Ann: Appendix 4C - quarterly, page-2

R&D for the qtr was $395k, forecast for next qtr is $800k, that is 200% increase in spending for R&D.

AKP is so far away from a commercial product at this stage it's not even funny. Seems they are doubling down on R&D to try and fast-track (if you can call it that) some progress. I would guess that interested parties signed to NDA's are getting over the continued delays and are exerting some pressure onto AKP to start performing.